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of the diet—within the ranges recommended by different 
guidelines—with metabolic risk factors.
Methods We studied 1785 people with type 2 diabetes, 
aged 50–75, enrolled in the TOSCA.IT Study. Dietary hab-
its were assessed using a validated food-frequency ques-
tionnaire (EPIC). Anthropometry, fasting lipids, HbA1c 
and C-reactive protein (CRP) were measured.
Results Increasing fat intake from <25 to ≥35 % is 
associated with a significant increase in LDL-choles-
terol, triglycerides, HbA1c and CRP (p < 0.05). Increas-
ing carbohydrates intake from <45 to ≥60 % is associ-
ated with significantly lower triglycerides, HbA1c and 
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CRP (p < 0.05). A fiber intake ≥15 g/1000 kcal is associ-
ated with a better plasma lipids profile and lower HbA1c 
and CRP than lower fiber consumption. A consumption of 
added sugars of ≥10 % of the energy intake is associated 
with a more adverse plasma lipids profile and higher CRP 
than lower intake.
Conclusions In people with type 2 diabetes, variations in 
the proportion of fat and carbohydrates of the diet, within 
the relatively narrow ranges recommended by different 
nutritional guidelines, significantly impact on the meta-
bolic profile and markers of low-grade inflammation. The 
data support the potential for reducing the intake of fat 
and added sugars, preferring complex, slowly absorbable, 
carbohydrates.
Keywords Diet · Carbohydrates · Fat · Glucose control · 
HDL-cholesterol · Triglycerides · Type 2 diabetes · 
Nutritional guidelines
Introduction
The medical nutrition therapy is a cornerstone in the 
treatment of diabetes; the main goal is to improve glu-
cose control and the cardiovascular risk factors profile [1, 
2]. Whereas it is well established that caloric restriction 
ameliorates glucose control and the plasma lipids profile, 
mainly through weight loss [3], the optimal macronutri-
ent composition of the diet for the management of patients 
with type 2 diabetes is still debated. A high protein intake 
is generally not recommended for patients with diabetes 
[4]. Therefore, the macronutrient composition of the diet 
is mainly regulated by the carbohydrate-to-fat ratio, but 
the ideal proportion of these main food components that 
should be recommended remains controversial [5–10]. The 
British Diabetes Association, European Association for the 
Study of Diabetes (EASD), American Diabetes Associa-
tion (ADA), American Heart Association, Canadian Diabe-
tes Association, International College of Nutrition, groups 
from South Africa and Japan, and the National Cholesterol 
Education Panel (Adult Treatment Panel 3) have slightly 
different recommendations for the optimal diet in people 
with type 2 diabetes [11–16]. The recommended intake of 
fat ranges from <25 to 35 % of total energy intake, whereas 
the recommended carbohydrates intake varies from 45 
to 60 % [17]. Restriction of added sucrose or fructose to 
a maximum of 10 % of the total energy intake, and fiber 
intake between 20 and 35 g/day are generally recom-
mended. The importance of quality of specific macro-
nutrients and individualized dietary goals is generally 
emphasized.
One major criticism to these guidelines is that there is 
insufficient evidence to justify the recommendations. Stud-
ies designed to compare the metabolic effects of the various 
dietary approaches suggested by different organizations for 
diabetes management are lacking. In particular, the meta-
bolic effects of diets with different proportions of fat and 
carbohydrates—within the ranges recommended by the 
nutritional guidelines—have not been explored. Expanding 
knowledge on this topic would be relevant to help clinicians 
in the choice of the most suitable dietary intervention(s) to 
improve the metabolic and cardiovascular risk factors pro-
file in people with diabetes.
The aim of the study is to characterize the habitual 
diet of a large cohort of people with type 2 diabetes and 
to explore, in real-life clinical practice, the association of 
different proportions of fat and carbohydrates of the diet—
within the ranges recommended by different authorities—
with metabolic risk factors. The association of fiber and 
added sugar with metabolic risk factors is also analyzed.
Materials and methods
We studied 1785 men and women with type 2 diabetes, 
aged 50–75 years, enrolled in the TOSCA.IT Study, a ran-
domized clinical trial (clinicaltrials.gov NCT00700856) 
designed to compare the impact of glucose lowering drugs 
on cardiovascular event. For the purposes of the present 
analysis, we used baseline data, collected prior to rand-
omization to study treatment. The study protocol has been 
approved by the Ethics Review Committee of the coor-
dinating center and of each participating center; written 
informed consent was obtained from all participants. The 
details of the study protocol have been published [18]. Body 
weight, height, waist and hip circumference were measured 
according to a standard protocol. Body mass index (BMI) 
was calculated as weight (kg)/height (m2). Biochemical 
analyses were performed in a central laboratory on fasting 
samples. Total cholesterol, HDL-cholesterol and triglycer-
ides were measured by standard methods. LDL-cholesterol 
was calculated according to the Friedewald equation [19] 
for people with triglycerides values <400 mg/dl. HbA1c 
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was measured with high-performance liquid chromatogra-
phy (HPLC), and high-sensitivity C-reactive protein (CRP) 
was measured by Tina-Quant on Roche/Hitachi 904. At the 
time of the study, all patients were treated with metformin 
only: 62 % were on lipid-lowering medications and 90 % 
were on antihypertensive drugs.
The dietary habits were assessed with the Italian version 
of the European Prospective Investigation into Cancer and 
Nutrition (EPIC) questionnaire [20, 21]. The questionnaire 
contains 248 items including the type of fat used as condi-
ment, or added after cooking. The respondent indicates the 
absolute frequency of consumption of each item (per day, 
week, month or year). The quantity of the food consumed 
was assessed on the basis of the respondent’s selection of 
an image of a food portion showing a small, medium and 
large portion size, with additional quantifiers (e.g., “smaller 
than the small portion” or “between the small and medium 
portion”). The nutrient composition of the diet, the glyce-
mic index and the glycemic load were calculated with the 
use of a software containing the Italian Food Tables [22, 
23] and the International Tables of Glycemic Index [24]. 
Incomplete questionnaires and questionnaires with implau-
sible data (i.e., energy intake <800 or >5000 kcal/day) were 
excluded from the analyses.
Statistical analysis
Data are given as mean and standard deviation or number 
and proportion, as appropriate. Not normally distributed 
variables were logarithmically transformed for statisti-
cal analyses and back-transformed into natural units for 
presentation in text and tables. For analytical purposes, 
Table 1  Clinical characteristics 
of the study participants and 
composition of the diet
Data are given as mean ± standard deviation or proportions
Clinical characteristics
N (% men) 1785 (57.7)
Age (years) 62.0 ± 6.5
BMI (Kg/m2) 30.4 ± 4.4
HbA1c (%) 7.70 ± 0.50
HDL-cholesterol (mg/dl) 45.5 ± 11.9
LDL-cholesterol (mg/dl) 103.4 ± 30.8
Triglycerides (mg/dl) 153.4 ± 76.8
Composition of the diet Ranges of recommended intake (Ref. [17])
Energy (Kcal/day) 1898 ± 673
Proteins (% of energy) 18.2 ± 2.5 10–20
Fat (% of energy) 36.6 ± 6.0 25–35
Saturated fatty acids (% of energy) 12.1 ± 2.5
Carbohydrates (% of energy) 45.1 ± 7.2 45–60
Fiber (g/day) 19.4 ± 2.7 20–35
Glycaemic index (%) 51.7 ± 3.3
Added sugar (% of energy) 2.9 ± 3.9
Table 2  Plasma lipids, HbA1c and CRP by intake of fat and carbohydrates (% of energy intake)
Data are given as mean ± standard deviation or proportions
* p < 0.05, general linear model (ANCOVA)
Measurements Fat (% of energy intake) Carbohydrates (% of energy intake)
Total population <25 (n = 48) 25–34 (n = 650) ≥35 (n = 1070) <45 (n = 887) 45–59 (n = 857) ≥60 (n = 31)
LDL-cholesterol (mg/dl) 102.0 ± 3.5 103.3 ± 3.6 103.7 ± 3.7* 103.6 ± 3.6 103.5 ± 3.6 103.0 ± 4.3
HDL-cholesterol (mg/dl) 46.1 ± 3.7 45.5 ± 3.9 45.5 ± 3.8 45.5 ± 3.7 45.5 ± 3.9 47.0 ± 3.9
Triglycerides (mg/dl) 148.3 ± 13.6 152.4 ± 15.2 154.5 ± 16.0* 154.4 ± 15.8 153.1 ± 15.6 144.4 ± 11.6*
HbA1c (%) 7.67 ± 0.08 7.70 ± 0.08 7.71 ± 0.08* 7.70 ± 0.08 7.69 ± 0.08 7.66 ± 0.07*
CRP (mg/dl) 1.25 ± 0.11 1.29 ± 0.13 1.31 ± 0.14* 1.31 ± 0.14 1.29 ± 0.13 1.24 ± 0.09*
% on lipid-lowering medications 63.8 59.1 58.8 55.1 57.7 61.3
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the dietary intake of the macronutrients of interest was 
divided into arbitrary categories which reflect the cutoff 
points derived from different nutritional recommendations 
(reviewed in [17]), that is, <25 %, 25–34 % or ≥35 % for 
total fat intake; <45 %, 45–59 % or ≥60 % for CHO; <10, 
10–14 or ≥15 g/1000 kcal for fiber and <5 %, 5–9 % or 
≥10 % for added sugar. Plasma lipids, HbA1c and CRP 
were analyzed across categories of fat, CHO, fiber intake 
and added sugar by analysis of variance (ANOVA) with 
post hoc test (Bonferroni). Adjustment for covariates was 
performed with the general linear model (ANCOVA). The 
statistical significance was defined as p < 0.05, two sided. 
All statistical analyses were performed with the SPSS soft-
ware for Windows, version 20.0.
Results
Table 1 gives the clinical characteristics of the study par-
ticipants along with the composition of the diet and the 
Table 3  Plasma lipids, HbA1c and CRP by intake of fiber (g/1000 kcal/day) and added sugar (% of energy intake)
Data are given as mean ± standard deviation or proportions
* p < 0.05, general linear model (ANCOVA)
Measurements Fiber (g/1000 kcal/day) Added sugar (% of energy intake)
Total population <10 (n = 721) 10–14 (n = 932) ≥15 (n = 133) <5 (n = 1433) 5–9 (n = 245) ≥10 (n = 90)
LDL-cholesterol (mg/dl) 103.5 ± 3.6 103.4 ± 3.7 103.8 ± 3.7 103.4 ± 3.6 103.7 ± 3.9 103.9 ± 4.1
HDL-cholesterol (mg/dl) 44.9 ± 3.8 45.8 ± 3.7 46.9 ± 3.7* 45.6 ± 3.8 45.2 ± 4.0 45.6 ± 3.7
Triglycerides (mg/dl) 155.0 ± 15.9 153.1 ± 15.6 149.3 ± 14.5* 153.1 ± 15.5 155.8 ± 17.1 155.2 ± 14.8*
HbA1c (%) 7.71 ± 0.08 7.69 ± 0.08 7.67 ± 0.08* 7.69 ± 0.08 7.71 ± 0.09 7.72 ± 0.08*
CRP (mg/dl) 1.30 ± 0.13 1.29 ± 0.14 1.28 ± 0.13* 1.30 ± 0.14 1.32 ± 0.14 1.33 ± 0.14*
% on lipid-lowering medications 54.3 57.5 57.9 54.6 57.2 58.9
Table 4  Plasma lipids, HbA1c and CRP by intake of fat and carbohydrates (% of energy intake) in the subsample not on lipid-lowering medica-
tions
Data are given as mean ± standard deviation
* p < 0.05, general linear model (ANCOVA)
Measurements Fat (% of energy intake) Carbohydrates (% of energy intake)
<25 (n = 15) 25–34 (n = 282) ≥35 (n = 499) <45 (n = 419) 45–59 (n = 365) ≥60 (n = 12)
LDL-cholesterol (mg/dl) 101.6 ± 2.8 103.3 ± 3.3 103.8 ± 3.4* 103.7 ± 3.4 103.5 ± 3.3 103.2 ± 4.0
HDL-cholesterol (mg/dl) 45.5 ± 3.7 45.3 ± 3.7 45.1 ± 3.6 45.1 ± 3.6 45.2 ± 3.8 46.0 ± 3.7
Triglycerides (mg/dl) 148.9 ± 14.5 153.6 ± 15.0 156.2 ± 15.6* 155.5 ± 15.2 155.0 ± 15.7 147.6 ± 13.9*
HbA1c (%) 7.67 ± 0.07 7.70 ± 0.08 7.71 ± 0.08* 7.71 ± 0.08 7.70 ± 0.08 7.67 ± 0.06*
CRP (mg/dl) 1.25 ± 0.13 1.29 ± 0.14 1.31 ± 0.15* 1.31 ± 0.14 1.30 ± 0.14 1.25 ± 0.12*
Table 5  Plasma lipids, HbA1c and CRP by intake of fiber (g/1000 kcal/day) and added sugar (% of energy intake) in the subsample not on 
lipid-lowering medications
Data are given as mean ± standard deviation
* p < 0.05, general linear model (ANCOVA)
Measurements Fiber (g/1000 kcal/day) Added sugar (% of energy intake)
<10 (n = 344) 10–14 (n = 396) ≥15 (n = 56) <5 (n = 656) 5–9 (n = 107) ≥10 (n = 33)
LDL-cholesterol (mg/dl) 103.5 ± 3.3 103.7 ± 3.4 103.4 ± 3.4 103.4 ± 3.3 104.2 ± 3.6 105.1 ± 3.4*
HDL-cholesterol (mg/dl) 44.5 ± 3.7 45.5 ± 3.6 47.0 ± 3.2* 45.2 ± 3.7 44.5 ± 3.7 45.6 ± 3.7
Triglycerides (mg/dl) 157.5 ± 15.7 154.1 ± 15.3 147.9 ± 11.1* 154.3 ± 15.3 159.1 ± 15.7 158.1 ± 15.3*
HbA1c (%) 7.72 ± 0.08 7.70 ± 0.07 7.67 ± 0.06* 7.70 ± 0.08 7.73 ± 0.08 7.72 ± 0.08*
CRP (mg/dl) 1.31 ± 0.14 1.30 ± 0.15 1.28 ± 0.13* 1.30 ± 0.14 1.33 ± 0.14 1.35 ± 0.14*
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range of intake for proteins, fat, carbohydrates and fiber, 
recommended by various authorities and summarized in 
reference [17]. On average, the study participants are over-
weight/obese, 75 % have abdominal obesity (i.e., waist cir-
cumference above 102 cm for men, or 88 cm for women) 
[16]. The glucose control and the plasma lipids profile are 
close to the treatment targets recommended by the Italian 
standards of care for people with type 2 diabetes [25]. The 
energy intake is high (1898 ± 673 kcal) considering the 
elevated BMI. The total and saturated fat content of the diet 
is slightly above recommended. The average carbohydrates 
content is in the low recommended range (45.1 ± 7.2 % of 
total energy); the glycemic index is low (51.7 ± 3.3 %), 
which suggests that the carbohydrates of the diet are largely 
represented by slowly absorbable carbohydrates. The fiber 
intake is lower than recommended (19.4 ± 2.7 g/day).
As expected, the energy intake is directly associated with 
plasma triglycerides and inversely associated with HDL-
cholesterol; no association with LDL-cholesterol, HbA1c 
and CRP was observed (data not shown). In order to correct 
for the effect of energy intake in further analyses, the intake 
of fat, carbohydrates and added sugar is expressed as pro-
portion (%) of the total energy of the diet and the intake of 
dietary fiber is expressed as g/1000 kcal/day.
The increase in fat intake from <25 to 35 % or more is 
associated with a significant increase in LDL-cholesterol, 
triglycerides, HbA1c and CRP (p < 0.05 for all) with a sig-
nificant linear trend (Table 2). To the contrary, increasing 
carbohydrates intake from <45 to 60 % or more is associ-
ated with significantly lower triglycerides, HbA1c and CRP 
(p < 0.05 for all), whereas no changes are observed for 
LDL- or HDL-cholesterol (Table 2).
A consumption of fiber ≥15 g/1000 kcal is associated 
with significantly lower triglycerides, HbA1c and CRP, 
and higher HDL-cholesterol, compared with a fiber intake 
<10 g/1000 kcal (Table 3). To the contrary, plasma triglyc-
erides, HbA1c and CRP increase progressively and sig-
nificantly with the increasing consumption of added sugar, 
whereas no effect is observed for LDL- or HDL-cholesterol 
(Table 3).
The proportion of study participants on lipid-lowering 
agents is not significantly different across the categories 
of the nutrients intakes considered (Tables 2, 3). A sensi-
tivity analysis, conducted with the exclusion of people on 
hypolipidemic drugs confirmed the findings (Tables 4, 5).
Discussion
Although central to medical nutrition therapy, the associa-
tion of dietary approaches with different proportions of fat 
and carbohydrates and metabolic risk factors in patients 
with type 2 diabetes has been little explored. The only 
meta-analysis which has been performed to quantify the 
probable metabolic effects of different fat and carbohy-
drates proportions in people with diabetes was based on 
intervention studies conducted in small groups of selected 
patients [5]. Some of the dietary approaches tested included 
a carbohydrates content as high as 75 % and a fat content 
as low as 10 % which are out of the recommend ranges for 
people with diabetes and are also difficult to adhere with 
in the long term. In addition, studies investigating high-
carbohydrates diets also high in dietary fiber were excluded 
from this analysis [5]. To our knowledge, the present study 
is the first to characterize the habitual diet of a large cohort 
of people with type 2 diabetes and to explore, in real-life 
clinical practice, the association of different proportions of 
dietary fat and carbohydrates with metabolic risk factors.
The study shows that relatively small variations in the 
proportion of fat and carbohydrate—within the ranges rec-
ommended by most organizations (reviewed in [17])—are 
significantly associated with metabolic risk factors and 
low-grade inflammation, independent of energy intake and 
use of hypoglycemic drugs. The increase in fat intake from 
<25 to ≥35 % is associated with a significant increase in 
LDL-cholesterol, triglycerides, HbA1c and CRP, whereas 
the increase in carbohydrates intake from <45 to ≥60 % 
is associated with significantly lower triglycerides, HbA1c 
and CRP.
The optimal proportion of fat and CHO of the diet for 
the management of diabetes is debated [5–10]. Most, 
though not all, studies show that low-fat/high-carbohy-
drates diets have a negative impact on plasma triglycer-
ides, HDL-cholesterol, insulin resistance and glucose con-
trol [10, 26–28]. The inconsistent findings can be partly 
explained by differences in the design and analysis of these 
studies. The lack of standard definitions for high (low)-fat 
and high (low)-carbohydrates diet makes it difficult to com-
pare different studies. Furthermore, correction for energy 
intake is not always performed and the source and quality 
of carbohydrates is rarely taken into account.
In our study population, the main source of carbohy-
drates is represented by slowly absorbable carbohydrates, 
as suggested by the low glycemic index of the diet. These 
characteristics may largely account for the lack of detri-
mental associations of high carbohydrates consumption 
with plasma lipids, glucose control and low-grade inflam-
mation. In line with this hypothesis, we find that increas-
ing the intake of fiber is associated with lower triglycerides 
and CRP and higher HDL-cholesterol levels, whereas the 
increase in the consumption of added sugars is associated 
with significantly higher plasma triglycerides, higher CRP 
and lower HDL-cholesterol. These findings are quite new; 
whereas the association of dietary fiber with LDL-choles-
terol has been extensively investigated, little information 
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exists on triglycerides, HDL-cholesterol levels and markers 
of low-grade inflammation.
Although small in magnitude, the observed metabolic 
changes are coherent with the results of lifestyle interven-
tions studies [29, 30] and, if translated at the population 
level, may significantly impact on the population’s absolute 
cardiovascular risk.
The large study population representative of the gen-
eral diabetic population commonly seen in real-life clini-
cal practice and the central measurement of the metabolic 
variables (plasma lipids, HbA1c, CRP) are the major study 
strengths. Among the study limitations, we must acknowl-
edge the observational design and the extensive use of 
hypolipidemic drugs which, although equally distributed 
across categories of nutrients intake, may have partly off-
set the quantitative effect of nutritional factors. However, a 
sensitivity analysis, performed after exclusion of people on 
hypolipidemic drugs, confirmed the results, thus strength-
ening the findings.
In summary, the study shows that in people with type 2 
diabetes, changes in the proportion of fat and CHO of the 
diet within the relatively narrow ranges proposed by dif-
ferent authorities are associated with significant changes 
of the metabolic profile and low-grade inflammation The 
study provides strong observational data in support of the 
potential for reducing dietary fat intake and added sugars, 
preferring complex, slowly absorbable, carbohydrates in 
the habitual diet for patients with type 2 diabetes.
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